Literature DB >> 11274271

Clinicopathological correlation in biopsy-proven atherosclerotic nephropathy: implications for renal functional outcome in atherosclerotic renovascular disease.

J R Wright1, A Duggal, R Thomas, R Reeve, I S Roberts, P A Kalra.   

Abstract

BACKGROUND: Atherosclerotic renovascular disease (ARVD) is commonly associated with renal failure. It is now recognized that intrarenal damage, (ischaemic or atherosclerotic nephropathy) is a major contributor to the renal impairment in these patients. In this study the impact of histological changes upon renal functional outcome was investigated in patients with atherosclerotic nephropathy.
METHODS: The Hope Hospital renal biopsy database (1985-1998) was interrogated for patients with histology compatible with atherosclerotic nephropathy. Case-note review enabled the assessment of several clinical parameters and outcomes, including change in creatinine clearance per year (DeltaCrCl (ml/min/year)), blood pressure control, dialysis need, and death. Renal parenchymal damage was analysed by morphometric analysis (of interstitial fibrosis and glomerulosclerosis) and a semi-quantitative chronic damage score (score 0-3 (normal-severe) for each of glomerulosclerosis, interstitial fibrosis, tubular atrophy, and arteriolar hyalinosis; maximum=12). Patients were stratified into two groups who had either deteriorating (group 1) or stable (group 2) renal function during follow-up.
RESULTS: Twenty-five patients (age 64.7+/-10.5, range 43-83 years; 17 male, eight female) were identified. Sixteen patients had undergone angiography; two had significant (>50%) renal artery stenosis. Mean follow-up was 25.6+/-14.8 (range 5-50) months. Group 1 patients had DeltaCrCl -7.4+/-6.8 ml/min/year, n=14 and group 2 patients had DeltaCrCl 4.8+/-7.0 ml/min/year, n=11. Four patients in group 1 developed end-stage renal disease and five patients died (three in group 1 and two in group 2). At study entry, group 1 patients had worse renal function (CrCl 27.6+/-17.6 vs 36.0+/-33.9, NS), greater proteinuria (1.2 vs 0.5 g/24 h, NS), and higher systolic blood pressure (167.1+/-30.8 mmHg vs 150.6+/-37.8, NS) compared with group 2 patients. Group 1 patients showed more glomerulosclerosis (51.6 vs 24.9%, P:<0.01), greater proportional interstitial volume (44.9 vs 33.9%, P:<0.02), and higher overall chronic damage score (P:<0.05) than those in group 2. There was a significant correlation between renal functional outcome and chronic damage score, glomerulosclerosis and proportional interstitial volume for the entire patient cohort.
CONCLUSION: In patients with atherosclerotic nephropathy the severity of histopathological damage is an important determinant and predictor of renal functional outcome.

Entities:  

Mesh:

Year:  2001        PMID: 11274271     DOI: 10.1093/ndt/16.4.765

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  32 in total

Review 1.  Renovascular hypertension: screening and modern management.

Authors:  Iris Baumgartner; Lilach O Lerman
Journal:  Eur Heart J       Date:  2011-01-27       Impact factor: 29.983

2.  Ischaemic nephropathy secondary to atherosclerotic renal artery stenosis: clinical and histopathological correlates.

Authors:  Mira T Keddis; Vesna D Garovic; Kent R Bailey; Christina M Wood; Yassaman Raissian; Joseph P Grande
Journal:  Nephrol Dial Transplant       Date:  2010-05-25       Impact factor: 5.992

3.  Inflammatory and injury signals released from the post-stenotic human kidney.

Authors:  Alfonso Eirin; Monika L Gloviczki; Hui Tang; Mario Gössl; Kyra L Jordan; John R Woollard; Amir Lerman; Joseph P Grande; Stephen C Textor; Lilach O Lerman
Journal:  Eur Heart J       Date:  2012-07-06       Impact factor: 29.983

4.  Oral supplement of six selective amino acids arrest progression renal failure in uremic patients.

Authors:  Hippocrates Yatzidis
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

Review 5.  Chronic renal ischemia in humans: can cell therapy repair the kidney in occlusive renovascular disease?

Authors:  Ahmed Saad; Sandra M Herrmann; Stephen C Textor
Journal:  Physiology (Bethesda)       Date:  2015-05

6.  Preserved oxygenation despite reduced blood flow in poststenotic kidneys in human atherosclerotic renal artery stenosis.

Authors:  Monika L Gloviczki; James F Glockner; Lilach O Lerman; Michael A McKusick; Sanjay Misra; Joseph P Grande; Stephen C Textor
Journal:  Hypertension       Date:  2010-03-01       Impact factor: 10.190

7.  Genetic deficiency of Smad3 protects the kidneys from atrophy and interstitial fibrosis in 2K1C hypertension.

Authors:  Gina M Warner; Jingfei Cheng; Bruce E Knudsen; Catherine E Gray; Ansgar Deibel; Justin E Juskewitch; Lilach O Lerman; Stephen C Textor; Karl A Nath; Joseph P Grande
Journal:  Am J Physiol Renal Physiol       Date:  2012-02-29

Review 8.  Diagnostic criteria for renovascular disease: where are we now?

Authors:  Sandra M S Herrmann; Stephen C Textor
Journal:  Nephrol Dial Transplant       Date:  2012-07       Impact factor: 5.992

Review 9.  Emerging Paradigms in Chronic Kidney Ischemia.

Authors:  Alfonso Eirin; Stephen C Textor; Lilach O Lerman
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

10.  Changes in glomerular filtration rate after renal revascularization correlate with microvascular hemodynamics and inflammation in Swine renal artery stenosis.

Authors:  Alfonso Eirin; Behzad Ebrahimi; Xin Zhang; Xiang-Yang Zhu; Hui Tang; John A Crane; Amir Lerman; Stephen C Textor; Lilach O Lerman
Journal:  Circ Cardiovasc Interv       Date:  2012-10-09       Impact factor: 6.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.